- Report
- March 2023
- 80 Pages
France
From €1320EUR$1,500USD£1,155GBP
- Report
- March 2023
- 80 Pages
China
From €1320EUR$1,500USD£1,155GBP
- Report
- March 2023
- 80 Pages
South Korea
From €1320EUR$1,500USD£1,155GBP
From €1320EUR$1,500USD£1,155GBP
- Report
- April 2024
- 200 Pages
Global
From €3389EUR$3,850USD£2,964GBP
€4269EUR$4,850USD£3,734GBP
- Report
- February 2026
China
From €3512EUR$3,990USD£3,072GBP
- Report
- February 2026
United Kingdom
From €3512EUR$3,990USD£3,072GBP
- Report
- February 2026
United Kingdom
From €3512EUR$3,990USD£3,072GBP
- Report
- February 2026
- 70 Pages
China
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Mexico
From €1188EUR$1,350USD£1,039GBP
From €879EUR$999USD£769GBP
- Report
- April 2025
- 107 Pages
China
From €1584EUR$1,800USD£1,386GBP
- Report
- April 2025
- 54 Pages
China
From €1584EUR$1,800USD£1,386GBP
- Report
- February 2025
- 130 Pages
Global
From €4269EUR$4,850USD£3,734GBP
- Report
- December 2024
- 199 Pages
United States
From €4885EUR$5,550USD£4,273GBP
- Report
- March 2024
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- March 2024
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- August 2023
- 115 Pages
Global
From €3961EUR$4,500USD£3,464GBP
- Drug Pipelines
- March 2023
- 125 Pages
Global
From €13199EUR$14,995USD£11,544GBP
- Report
- March 2023
- 132 Pages
Global
From €836EUR$950USD£731GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more